US2009281147A1PendingUtilityA1
Method of treating of demyelinating diseases or conditions
Est. expiryFeb 15, 2021(expired)· nominal 20-yr term from priority
A61P 9/10A61P 9/00A61P 43/00A61P 35/00A61P 37/00A61P 25/28A61P 27/02A61P 25/02A61P 25/04A61P 29/00A61P 3/00A61P 25/00A61P 13/02A61P 17/02A61P 13/10A61P 19/08A61P 19/00A61P 19/02A61P 13/00A61K 31/4439
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
N-(Pyridinyl)-1H-indol-1-amines of formula I provide a unique combination of blocking properties for both the potassium and sodium channels. These compounds are useful for the treatment of Demyelinating Diseases and Conditions such as Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury and Stroke. The compounds are also useful for Stroke Rehabilitation, the treatment of Bladder Irritation and Dysfunction, and the treatment of Neuropathic Pain and Chemokine-Induced Pain.
Claims
exact text as granted — not AI-modified1 . A method for treating multiple sclerosis, in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound of formula
or a pharmaceutically acceptable salt thereof.
2 . The method according to claim 1 , wherein the pharmaceutically acceptable salt is hydrochloride salt.Join the waitlist — get patent alerts
Track US2009281147A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.